HYPERION DEFI, INC. Financing Cash Flow
HYPERION DEFI, INC. (HYPD) reported Financing Cash Flow of $17.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $10.77M, a 79.52% decline year-over-year.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $6.61M, a 5.60% increase year-over-year.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $8.60M, a 723.27% increase year-over-year.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $23.63M, a 118.10% increase year-over-year.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for fiscal 2025 was $91.05M, a 418.64% increase from fiscal 2024.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for fiscal 2024 was $17.55M, a 11.31% decline from fiscal 2023.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for fiscal 2023 was $19.79M, a 7.97% decline from fiscal 2022.
- HYPERION DEFI, INC. net cash provided by (used in) financing activities for fiscal 2022 was $21.51M, a 0.23% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $17.37M 10-Q · filed 2026-08-13 | $25.97M derived: sum of 3 quarters · filed 2026-08-13 | $49.60M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $6.61M 10-Q · filed 2026-05-15 | $15.20M derived: sum of 2 quarters · filed 2026-05-15 | $38.83M derived: sum of 3 quarters · filed 2026-05-15 | $91.40M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $32.22M derived: sum of 2 quarters · filed 2026-03-30 | $84.79M derived: sum of 3 quarters · filed 2026-08-13 | $91.05M 10-K · filed 2026-03-30 |
| 2025-09-30 | $23.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $76.19M derived: sum of 2 quarters · filed 2026-08-13 | $82.45M 10-Q · filed 2025-11-14 | $83.49M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $52.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $58.82M 10-Q · filed 2026-08-13 | $59.87M derived: sum of 3 quarters · filed 2026-08-13 | $70.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $6.26M 10-Q · filed 2026-05-15 | $7.30M derived: sum of 2 quarters · filed 2026-05-15 | $18.13M derived: sum of 3 quarters · filed 2026-05-15 | $20.68M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $11.88M derived: sum of 2 quarters · filed 2026-03-30 | $14.42M derived: sum of 3 quarters · filed 2026-03-30 | $17.55M 10-K · filed 2026-03-30 |
| 2024-09-30 | $10.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $13.38M derived: sum of 2 quarters · filed 2025-11-14 | $16.51M 10-Q · filed 2025-11-14 | $17.12M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $2.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $5.68M 10-Q · filed 2025-08-13 | $6.29M derived: sum of 3 quarters · filed 2025-08-13 | $17.07M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $3.13M 10-Q · filed 2025-05-19 | $3.75M derived: sum of 2 quarters · filed 2025-05-19 | $14.53M derived: sum of 3 quarters · filed 2025-05-19 | $19.53M derived: sum of 4 quarters · filed 2025-05-19 |
| 2023-12-31 | $614.27K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $11.39M derived: sum of 2 quarters · filed 2025-04-15 | $16.39M derived: sum of 3 quarters · filed 2025-04-15 | $19.79M 10-K · filed 2025-04-15 |
| 2023-09-30 | $10.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $15.78M derived: sum of 2 quarters · filed 2024-11-12 | $19.18M 10-Q · filed 2024-11-12 | $22.48M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $8.40M 10-Q · filed 2024-08-14 | $11.71M derived: sum of 3 quarters · filed 2024-08-14 | $14.58M derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $3.40M 10-Q · filed 2024-05-15 | $6.71M derived: sum of 2 quarters · filed 2024-05-15 | $9.58M derived: sum of 3 quarters · filed 2024-05-15 | $9.26M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $3.31M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-18 | $6.18M derived: sum of 2 quarters · filed 2024-03-18 | $5.86M derived: sum of 3 quarters · filed 2024-03-18 | $21.51M 10-K · filed 2024-03-18 |
| 2022-09-30 | $2.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $2.55M derived: sum of 2 quarters · filed 2023-11-13 | $18.20M 10-Q · filed 2023-11-13 | $30.49M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$318.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $15.33M 10-Q · filed 2023-08-11 | $27.62M derived: sum of 3 quarters · filed 2023-08-11 | $27.43M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $15.65M 10-Q · filed 2023-05-12 | $27.94M derived: sum of 2 quarters · filed 2023-05-12 | $27.75M derived: sum of 3 quarters · filed 2023-05-12 | $35.65M derived: sum of 4 quarters · filed 2023-05-12 |
| 2021-12-31 | $12.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $12.10M derived: sum of 2 quarters · filed 2023-03-31 | $20.00M derived: sum of 3 quarters · filed 2023-03-31 | $21.46M 10-K · filed 2023-03-31 |
| 2021-09-30 | -$188.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $7.71M derived: sum of 2 quarters · filed 2022-11-14 | $9.17M 10-Q · filed 2022-11-14 | $9.26M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $7.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $9.36M 10-Q · filed 2022-08-11 | $9.45M derived: sum of 3 quarters · filed 2022-08-11 | $24.14M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $1.45M 10-Q · filed 2022-05-13 | $1.55M derived: sum of 2 quarters · filed 2022-05-13 | $16.24M derived: sum of 3 quarters · filed 2022-05-13 | $16.80M derived: sum of 4 quarters · filed 2022-05-13 |
| 2020-12-31 | $97.37K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $14.78M derived: sum of 2 quarters · filed 2022-03-30 | $15.35M derived: sum of 3 quarters · filed 2022-03-30 | $20.86M 10-K · filed 2022-03-30 |
| 2020-09-30 | $14.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $15.25M derived: sum of 2 quarters · filed 2021-11-12 | $20.77M 10-Q · filed 2021-11-12 | $20.77M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $566.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $6.08M 10-Q · filed 2021-08-12 | $6.08M derived: sum of 3 quarters · filed 2021-08-12 | $19.04M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $5.52M 10-Q · filed 2021-05-14 | $5.52M derived: sum of 2 quarters · filed 2021-05-14 | $18.47M derived: sum of 3 quarters · filed 2021-05-14 | $18.54M derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $12.96M derived: sum of 2 quarters · filed 2021-03-30 | $13.03M derived: sum of 3 quarters · filed 2021-03-30 | $13.51M 10-K · filed 2021-03-30 |
| 2019-09-30 | $12.96M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $13.03M derived: sum of 2 quarters · filed 2020-11-12 | $13.51M 10-Q · filed 2020-11-12 | $16.33M derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $67.89K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $551.78K 10-Q · filed 2020-08-14 | $3.37M derived: sum of 3 quarters · filed 2020-08-14 | $3.43M derived: sum of 4 quarters · filed 2020-08-14 |
| 2019-03-31 | $483.89K 10-Q · filed 2020-05-14 | $3.30M derived: sum of 2 quarters · filed 2020-05-14 | $3.36M derived: sum of 3 quarters · filed 2020-05-14 | $3.36M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $2.82M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.87M derived: sum of 2 quarters · filed 2020-03-30 | $2.87M derived: sum of 3 quarters · filed 2020-03-30 | $27.62M 10-K · filed 2020-03-30 |
| 2018-09-30 | $56.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $56.48K derived: sum of 2 quarters · filed 2019-11-13 | $24.80M 10-Q · filed 2019-11-13 | $24.64M derived: sum of 4 quarters · filed 2019-11-13 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $24.74M 10-Q · filed 2019-08-13 | $24.59M derived: sum of 3 quarters · filed 2019-08-13 | $31.35M derived: sum of 4 quarters · filed 2019-08-13 |
| 2018-03-31 | $24.74M 10-Q · filed 2019-05-14 | $24.59M derived: sum of 2 quarters · filed 2019-05-14 | $31.35M derived: sum of 3 quarters · filed 2019-05-14 | $31.35M derived: sum of 4 quarters · filed 2019-05-14 |
| 2017-12-31 | -$156.42K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-27 | $6.60M derived: sum of 2 quarters · filed 2019-03-27 | $6.60M derived: sum of 3 quarters · filed 2019-03-27 | $6.60M 10-K · filed 2019-03-27 |
| 2017-09-30 | $6.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.76M derived: sum of 2 quarters · filed 2018-11-13 | $6.76M 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $0.00 10-Q · filed 2018-08-14 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $4.14M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |